Clinical Trials Browser

Phase 1/2 × NIH × Graft vs Host Disease × Clear all

NCT03983850 2025-12-26

Optimizing PTCy Dose and Timing

Phase 1/2 Active not recruiting

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms